HikariQ, Inc announced that it has received an equity round of funding from Solasia Pharma K.K. on April 11, 2022. The investor will acquire 25% stake in the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25 JPY | -3.85% | 0.00% | -44.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.44% | 30.53M | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-22.99% | 29.36B | |
+57.67% | 24.49B | |
-15.17% | 17.31B | |
-19.57% | 11.62B | |
-15.61% | 11.31B | |
-44.23% | 11.26B | |
+5.84% | 8.31B |
- Stock Market
- Equities
- 4597 Stock
- News Solasia Pharma K.K.
- HikariQ, Inc announced that it has received funding from Solasia Pharma K.K.